{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"The distribution of duration of response will be estimated using the method of Kaplan-Meier.","groups":[{"description":"Patients receive oral sunitinib malate once daily on days 1-42. Treatment repeats every 42 days for up to 12 courses in the absence of disease progression or unacceptable toxicity.","id":"OG000","title":"Treatment (Kinase Inhibitor Therapy)"}],"populationDescription":"No analysis was done because there were no confirmed responses.","reportingStatus":"POSTED","timeFrame":"From the documentation of response until the date of progression","title":"Duration of Response","type":"SECONDARY"}